© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Phio Pharmaceuticals Corp. (PHIO) shows an Average True Range (ATR) of 0.1 and an Enterprise Value of -5.37M. Its average trading volume over the past 3 months is 2.97M, indicating liquidity. These fundamental metrics provide insight into PHIO's underlying financial health and market activity.
| ATR | 0.1 |
| Enterprise Value | -5.37M |
| Avg Vol (3 Months) | 2.97M |
| Avg Vol (10 Days) | 27.07M |
Phio Pharmaceuticals Corp. (PHIO) technical indicators as of February 11, 2026: the SMA 20 is 8.38%, SMA 50 at 1.84%, and SMA 200 at -39.63%. The RSI 14 value is 56.14, suggesting its current momentum. These technical analysis signals help assess PHIO's price trends and potential future movements.
| SMA 20 | 8.38% |
| SMA 50 | 1.84% |
| SMA 200 | -39.63% |
| RSI 14 | 56.14 |
Phio Pharmaceuticals Corp. (PHIO) stock performance overview as of February 11, 2026: The 52-week high is $4.19 (currently -73.27% below), and the 52-week low is $0.813 (currently 37.81% above). Over the past year, PHIO's performance is -62.89%, compared to the S&P 500's 8.87% change.
| 52-Week High | 4.19 |
| 52-Week High Chg | -73.27% |
| 52-Week Low | 0.8127 |
| 52-Week Low Chg | +37.81% |
| S&P 500 52-Week Chg | 8.87% |
According to market data, Phio Pharmaceuticals Corp. (PHIO) stock's recent performance metrics show that over the last month, PHIO is 0.93%, with a Year-to-Date (YTD) performance of 2.86%. Over the past year, the stock has seen a -62.89% change. These figures summarize PHIO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.48 | 1.48 | 1.64 | 4.19 | 4.19 | 1.48 |
| Low | 0.8127 | 0.8127 | 0.8127 | 0.8127 | 0.8127 | 0.8127 |
| Performance | -9.24% | +0.93% | -48.82% | -54.81% | -62.89% | +2.86% |
According to current financial data, PHIO stock's P/E (TTM) ratio is -0.81, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for PHIO, including P/S (N/A), P/B (0.66), and P/FCF (-1.74), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | PHIO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.81 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 0.66 | N/A | 18.62 | 5.42 |
| P/FCF (TTM) | -1.74 | -7.44 | -191.1 | 31.77 |